Literature DB >> 11790514

Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys.

J David Jentsch1, Peter Olausson, Richard De La Garza, Jane R Taylor.   

Abstract

The current experiments examined the effects of acute or repeated, intermittent administrations of cocaine on the acquisition and reversal of object discriminations by Vervet monkeys in order to test the hypothesis that cocaine treatment affects performance of tasks that depend upon the functions of the orbitofrontal cortex and amygdala. An acute dose of cocaine (1 mg/kg; 20 min prior to testing) impaired reversal of a previously learned object discrimination but had no effect on acquisition of a novel one. Specific impairments of reversal learning were also observed in monkeys 9 and 30 days after repeated administrations of cocaine (2 or 4 mg/kg, once daily for 14 days) that were perseverative in nature, indicating persistent behavioral consequences of repetitive dosing. The results indicate that repeated cocaine administrations produce enduring impairments of object discrimination learning when the inhibition of a previously conditioned response is required. These findings suggest that long-term cocaine administration may disrupt orbitofrontal efferents to the striatum, resulting in impaired inhibition of established conditioned responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11790514     DOI: 10.1016/S0893-133X(01)00355-4

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  133 in total

1.  A web-based brain atlas of the vervet monkey, Chlorocebus aethiops.

Authors:  Roger P Woods; Scott C Fears; Matthew J Jorgensen; Lynn A Fairbanks; Arthur W Toga; Nelson B Freimer
Journal:  Neuroimage       Date:  2010-10-13       Impact factor: 6.556

2.  Acute cocaine administration depresses cortical activity.

Authors:  Heather Trantham-Davidson; Antonieta Lavin
Journal:  Neuropsychopharmacology       Date:  2004-11       Impact factor: 7.853

3.  Effects of cocaine rewards on neural representations of cognitive demand in nonhuman primates.

Authors:  Robert E Hampson; Linda J Porrino; Ioan Opris; Terrence Stanford; Sam A Deadwyler
Journal:  Psychopharmacology (Berl)       Date:  2010-09-24       Impact factor: 4.530

4.  Inactivation of the central nucleus of the amygdala reduces the effect of punishment on cocaine self-administration in rats.

Authors:  YueQiang Xue; Jeffery D Steketee; WenLin Sun
Journal:  Eur J Neurosci       Date:  2012-02-06       Impact factor: 3.386

5.  Performance on an impulse control task is altered in adult rats exposed to amphetamine during adolescence.

Authors:  Emily R Hankosky; Joshua M Gulley
Journal:  Dev Psychobiol       Date:  2012-07-06       Impact factor: 3.038

6.  Distinct prefrontal cortical regions negatively regulate evoked activity in nucleus accumbens subregions.

Authors:  Amber Asher; Daniel J Lodge
Journal:  Int J Neuropsychopharmacol       Date:  2011-10-19       Impact factor: 5.176

7.  Different functional domains measured by cocaine self-administration under the progressive-ratio and punishment schedules in male Wistar rats.

Authors:  Udita Datta; Mariangela Martini; WenLin Sun
Journal:  Psychopharmacology (Berl)       Date:  2017-12-06       Impact factor: 4.530

Review 8.  The role of orbitofrontal cortex in drug addiction: a review of preclinical studies.

Authors:  Geoffrey Schoenbaum; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2007-08-23       Impact factor: 13.382

9.  Abnormal ventromedial prefrontal cortex function in children with psychopathic traits during reversal learning.

Authors:  Elizabeth C Finger; Abigail A Marsh; Derek G Mitchell; Marguerite E Reid; Courtney Sims; Salima Budhani; David S Kosson; Gang Chen; Kenneth E Towbin; Ellen Leibenluft; Daniel S Pine; James R Blair
Journal:  Arch Gen Psychiatry       Date:  2008-05

Review 10.  PET studies in nonhuman primate models of cocaine abuse: translational research related to vulnerability and neuroadaptations.

Authors:  Robert W Gould; Angela N Duke; Michael A Nader
Journal:  Neuropharmacology       Date:  2013-02-28       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.